UB Paderborn / Katalog / Suche / in CDI

1 – 20 von 20

Sortiert nach

Clinical features and management of primary biliary cirrhosis

World journal of gastroenterology : WJG, 2008-06, Vol.14 (21), p.3313-3327

2008

Volltextzugriff (PDF)

PBC Screen: An IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis

Journal of autoimmunity, 2010-12, Vol.35 (4), p.436-442

2010

Volltextzugriff (PDF)

Severe azathioprine-induced liver injury 22 months after initiation of treatment

Drug and therapeutics bulletin, 2024-02, Vol.62 (4), p.60

2024

Volltextzugriff (PDF)

Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants

Human molecular genetics, 2012-12, Vol.21 (23), p.5209-5221

2012

Volltextzugriff (PDF)

Impact of Platelet Count on Perioperative Bleeding in Patients With Cirrhosis Undergoing Surgical Treatments of Liver Cancer

Hepatology communications, 2022-02, Vol.6 (2), p.423-434

2022

Volltextzugriff (PDF)

Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool

European journal of gastroenterology & hepatology, 2021-12, Vol.33 (1S Suppl 1), p.e266

2021

Volltextzugriff (PDF)

Role of Lipoylation of the Immunodominant Epitope of Pyruvate Dehydrogenase Complex: Toward a Peptide-Based Diagnostic Assay for Primary Biliary Cirrhosis

Journal of medicinal chemistry, 2015-08, Vol.58 (16), p.6619-6629

2015

Volltextzugriff (PDF)

Influenza A/H1N1 in patients with cystic fibrosis in Italy: a multicentre cohort study

Thorax, 2011-03, Vol.66 (3), p.260-261

2011

Volltextzugriff (PDF)

Liver involvement in cystic fibrosis: primary organ damage or innocent bystander?

Journal of hepatology, 2004-12, Vol.41 (6), p.1041-1044

2004

Volltextzugriff (PDF)

Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis

Journal of hepatology, 2001-03, Vol.34 (3), p.366-372

2001

Volltextzugriff (PDF)

Liver and Biliary Problems in Cystic Fibrosis

Seminars in liver disease, 1998, Vol.18 (3), p.227-235

1998

Volltextzugriff (PDF)

Liver involvement in cystic fibrosis

Journal of Hepatology, 1999-11, Vol.31 (5), p.946-954

1999

Volltextzugriff (PDF)

Vaccines in the 21st century: the genetic response and the innocent bystander

Autoimmunity reviews, 2005-02, Vol.4 (2), p.79-81

2005

Volltextzugriff (PDF)

Genetic variants of endothelial nitric oxide synthase in patients with primary biliary cirrhosis: Association with disease severity

Journal of gastroenterology and hepatology, 2003-10, Vol.18 (10), p.1150-1155

2003

Volltextzugriff (PDF)

Risk factors for the development of cystic fibrosis related liver disease

Hepatology (Baltimore, Md.), 2003-09, Vol.38 (3), p.775-776

2003

Volltextzugriff (PDF)

Ursodeoxycholic acid therapy in cystic fibrosis—associated liver disease: A dose‐response study

Hepatology (Baltimore, Md.), 1992-10, Vol.16 (4), p.924-930

1992

Volltextzugriff (PDF)

Hepatobiliary manifestations of cystic fibrosis

European journal of gastroenterology & hepatology, 1996-08, Vol.8 (8), p.748-754

1996

Volltextzugriff (PDF)

Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration

Hepatology (Baltimore, Md.), 1991-12, Vol.14 (6), p.1000-1007

1991

Volltextzugriff (PDF)

Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis : A dose-response study

Digestive diseases and sciences, 1996-04, Vol.41 (4), p.809-815

1996

Volltextzugriff (PDF)

Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: A study of bile acid metabolism

Hepatology (Baltimore, Md.), 1991-06, Vol.13 (6), p.1076-1083

1991

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Aktive Filter

ThemaFemale

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)
Japanisch
(4)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Clinical features and management of primary biliary cirrhosis

PBC Screen: An IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis

Severe azathioprine-induced liver injury 22 months after initiation of treatment

Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants

Impact of Platelet Count on Perioperative Bleeding in Patients With Cirrhosis Undergoing Surgical Treatments of Liver Cancer

Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool

Role of Lipoylation of the Immunodominant Epitope of Pyruvate Dehydrogenase Complex: Toward a Peptide-Based Diagnostic Assay for Primary Biliary Cirrhosis

Influenza A/H1N1 in patients with cystic fibrosis in Italy: a multicentre cohort study

Liver involvement in cystic fibrosis: primary organ damage or innocent bystander?

Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis

Liver and Biliary Problems in Cystic Fibrosis

Liver involvement in cystic fibrosis

Vaccines in the 21st century: the genetic response and the innocent bystander

Genetic variants of endothelial nitric oxide synthase in patients with primary biliary cirrhosis: Association with disease severity

Risk factors for the development of cystic fibrosis related liver disease

Ursodeoxycholic acid therapy in cystic fibrosis—associated liver disease: A dose‐response study

Hepatobiliary manifestations of cystic fibrosis

Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration

Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis : A dose-response study

Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: A study of bile acid metabolism

Aktive Filter

Suchergebnisse filtern